A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)
Status:
Active, not recruiting
Trial end date:
2023-09-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in
participants with advanced/metastatic Merkel cell carcinoma (MCC).